University of Minnesota Medical School launches clinical trial studying metformin treatment for COVID-19
15 mars 2021 09h54 HE
|
University of Minnesota Medical School
Minneapolis / St. Paul, March 15, 2021 (GLOBE NEWSWIRE) -- A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic...
aTyr Pharma Announces Positive Biomarker Data from Phase 2 Clinical Trial of ATYR1923 Demonstrating Anti-Inflammatory Effects in COVID-19 Patients with Severe Respiratory Complications
15 mars 2021 08h00 HE
|
aTyr Pharma, Inc.
Data provides first-in-patient mechanistic proof-of-concept for ATYR1923. ATYR1923 reduced key inflammatory cytokines that are implicated in sarcoidosis and other ILDs, consistent with findings...
Renibus Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2020
19 oct. 2020 09h00 HE
|
Rénibus Therapeutics Inc.
DALLAS, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it will present five abstracts at the American Society of...
aTyr Pharma Announces Phase 2 Study of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications Following FDA Acceptance of IND Application
21 avr. 2020 08h30 HE
|
aTyr Pharma, Inc.
SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)
15 avr. 2020 08h30 HE
|
Multiverse Investment Fund I, LP
Multiverse Investment Fund Portfolio Company Begins Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19) ARDS has been identified as the leading cause...
Informa Pharma Intelligence Launches Free COVID-19 Content Hub
07 avr. 2020 09h00 HE
|
Informa Business Intelligence
LONDON, April 07, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, today announces the launch of a free coronavirus (COVID-19/SARS-CoV-2) content hub designed to provide key information related...